Half Yearly Results Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Mar'25
Sep'24
Mar'24
Sep'23
Net Sales
400.20
347.75
272.68
184.90
29.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
400.20
347.75
272.68
184.90
29.04
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
401.97
314.69
226.62
149.69
14.45
(Increase) / Decrease In Stocks
-52.43
-13.29
5.23
0.67
-0.85
Employee Cost
6.22
7.22
5.89
4.02
3.29
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
17.53
14.61
14.44
10.57
2.88
Total Expenditure (Excl Depreciation)
373.29
323.23
252.18
164.95
19.77
Operating Profit (PBDIT) excl Other Income
26.91
24.52
20.50
19.95
9.27
Other Income
2.93
2.63
2.87
1.19
1.66
Operating Profit (PBDIT)
29.84
27.15
23.37
21.14
10.93
Interest
0.65
0.64
0.72
0.38
0.10
Exceptional Items
0.00
0.00
0.00
2.16
0.00
Gross Profit (PBDT)
29.19
26.51
22.65
22.92
10.83
Depreciation
1.29
1.16
0.38
0.59
0.42
Profit Before Tax
27.90
25.35
22.27
22.33
10.41
Tax
6.31
4.78
3.48
3.32
2.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
21.59
20.57
18.79
19.01
7.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
21.59
20.57
18.79
19.01
7.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
-2.16
Minority Interest
-4.09
-4.56
-4.78
-3.75
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.50
16.01
14.01
15.26
5.65
Equity Capital
11.78
5.89
5.89
1.47
1.47
Face Value
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
70.01
Earnings per share (EPS)
14.86
13.59
11.89
25.95
9.61
Diluted Earnings per share
18.33
17.46
11.89
8.07
10.38
Operating Profit Margin (Excl OI)
6.72%
7.05%
7.52%
10.79%
31.92%
Gross Profit Margin
7.29%
7.62%
8.31%
12.4%
37.29%
PAT Margin
5.39%
5.92%
6.89%
10.28%
26.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 15.08% vs 27.53% in Mar 2025
Consolidate Net Profit
Growth in half year ended Sep 2025 is 9.31% vs 14.28% in Mar 2025
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 9.75% vs 19.61% in Mar 2025
Interest
Growth in half year ended Sep 2025 is 1.56% vs -11.11% in Mar 2025
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Mar 2025
Compare Half Yearly Results Of Remus Pharma. With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
400.20
240.00
160.20
66.75%
Other Operating Income
0.00
0.00
0.00
Total Operating income
400.20
240.00
160.20
66.75%
Raw Material Cost
0.00
44.58
-44.58
-100.00%
Purchase of Finished goods
401.97
34.86
367.11
1,053.10%
(Increase) / Decrease In Stocks
-52.43
3.47
-55.90
-1,610.95%
Employee Cost
6.22
45.97
-39.75
-86.47%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
17.53
64.83
-47.30
-72.96%
Total Expenditure (Excl Depreciation)
373.29
193.70
179.59
92.72%
Operating Profit (PBDIT) excl Other Income
26.91
46.30
-19.39
-41.88%
Other Income
2.93
2.10
0.83
39.52%
Operating Profit (PBDIT)
29.84
48.40
-18.56
-38.35%
Interest
0.65
4.80
-4.15
-86.46%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
29.19
43.60
-14.41
-33.05%
Depreciation
1.29
4.86
-3.57
-73.46%
Profit Before Tax
27.90
38.74
-10.84
-27.98%
Tax
6.31
10.16
-3.85
-37.89%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
21.59
28.58
-6.99
-24.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
21.59
28.58
-6.99
-24.46%
Share in Profit of Associates
0.00
10.40
-10.40
-100.00%
Minority Interest
-4.09
0.00
-4.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.50
38.98
-21.48
-55.11%
Equity Capital
11.78
9.20
2.58
28.04%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
14.86
4.24
10.62
250.47%
Diluted Earnings per share
18.33
4.23
14.10
333.33%
Operating Profit Margin (Excl OI)
6.72%
19.29%
0.00
-12.57%
Gross Profit Margin
7.29%
18.17%
0.00
-10.88%
PAT Margin
5.39%
16.24%
0.00
-10.85%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 400.20 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 15.08% vs 27.53% in Mar 2025
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 17.50 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 9.31% vs 14.28% in Mar 2025
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.91 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 9.75% vs 19.61% in Mar 2025
Half Yearly - Interest
Interest 0.65 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 1.56% vs -11.11% in Mar 2025
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.72%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
